HOME >> MEDICINE >> NEWS
Preliminary study shows promise for treatment of renal cell cancer

A new study suggests that sunitinib is a promising agent for treatment of metastatic renal cell cancer, currently a disease without highly effective treatment options, according to an article in the June 7 issue of JAMA.

There is an urgent need for more active agents for the treatment of metastatic (spread of cancer from point of origin to another part of the body) renal cell carcinoma (RCC). The 5-year survival rate for metastatic RCC is estimated to be less than 10 percent, according to background information in the article. RCC is highly resistant to chemotherapy, and only a limited subset of patients (20 percent or less) benefit from cytokine (proteins from the immune system) therapy (high-dose interleukin-2 [IL-2] and/or interferon-alfa). Overall median survival following progression after cytokine therapy is approximately 10 to 13 months, and no effective treatment is available for patients whose disease progresses after an initial response, or who do not respond to cytokine therapy.

A better understanding of the genetic abnormalities associated with clear-cell RCC has helped identify new targets for therapy, and subsequently the development of a new therapy, the oral medication sunitinib, which had positive results in an initial study.

Robert J. Motzer, M.D., of Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a multicenter phase 2 trial to confirm the antitumor efficacy of sunitinib in 106 patients with metastatic clear-cell RCC whose disease was refractory (unresponsive) to 1 prior cytokine therapy. Patients were enrolled between February and November 2004, with follow-up continuing until disease progression, unacceptable toxicity, or withdrawal of consent. Patients received repeated 6-week cycles of sunitinib, 50 mg per day given orally for 4 consecutive weeks followed by 2 weeks off per treatment cycle.

"The results of this trial confirm that sunitinib given once daily according to a 4 weeks on/2
'"/>

Contact: Joanne Nicholas
212-639-3573
JAMA and Archives Journals
6-Jun-2006


Page: 1 2

Related medicine news :

1. Preliminary data update from Betaseron 16 yr. long-term follow-up study in patients with MS
2. Preliminary data suggest that soda and sweet drinks are the main source of calories in American diet
3. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
4. Penn study finds pro-death proteins required to regulate healthy immune function
5. New study shows promise in reducing surgical risks associated with surgical bleeding
6. New study counts the economic cost of persistent pain in Australia
7. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
8. Most seniors now have drug coverage, U-M study shows
9. To gain muscle and lose fat, drink milk: study
10. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
11. Even older women at high risk have little interest in being tested for HIV, study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... ... the American Foundation for Suicide Prevention’s (AFSP) annual signature event, Out of the ... hundreds of U.S. cities to raise awareness of suicide prevention. To ensure Associate ...
(Date:9/3/2020)... ... September 03, 2020 , ... International ... Technologies WALI wireless parking lot controller. This advanced LED wireless dimming controller, along ... trespass, and protecting the night sky against light pollution. Leo Smith, the Northeast ...
(Date:9/1/2020)... ... , ... Feeding Matters , the first organization in the world dedicated ... pleased to announce that the U.S. Centers for Disease Control and Prevention (CDC) has ... edition of the U.S. International Classification of Diseases (ICD ) on October 1, ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... of Blood Cancer Awareness Month (BCAM) and its international Light it Red ...
(Date:8/31/2020)... ... 2020 , ... Genesis Chiropractic Software and Billing Network ... of its integrated, HIPAA compliant, telehealth solution, available to US-based clients immediately. With ... seconds. , According to the U.S. Department of Health & Human Services, ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... ... can safely return to schools and classrooms across the United States, IntraLogic ... its technology product line. TEMPE is a non-contact, wall-mounted scanning thermometer that rapidly ...
(Date:9/1/2020)... SANTA CLARA, Calif. (PRWEB) , ... September 01, ... ... diagnostics, and analytical laboratory technologies, will host the Agilent Science and Technology ... , During this two-day symposium, Agilent will open a suite of Live webinars ...
(Date:9/1/2020)... ... , ... Breast and ovarian cancers are common diseases that affect many women. ... (about 7,500 women per year) and 10% of ovarian cancers (about 2,000 women per ... are detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, ...
Breaking Medicine Technology:
Cached News: